High prevalence of non-alcoholic fatty liver disease among hidradenitis suppurativa patients independent of classic metabolic risk factors

Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease

Inflamm Bowel Dis.

Glassner K, Malaty HM, Abraham BP

doi: 10.1097/

Psoriasis

High prevalence of alcohol use disorders in patients with inflammatory skin diseases

Br J Dermatol.

Al-Jefri K, Newbury-Birch D, Muirhead CR, Gilvarry E, Araújo-Soares V, Reynolds NJ, Kaner E, Hampton PJ

doi: 10.1111/bjd.15497.

Acne

Risk of connective tissue disease, morphea and systemic vasculitis in patients with hidradenitis suppurativa

J Eur Acad Dermatol Venereol.

Schneeweiss MC, Merola JF, Schneeweiss S, Wyss R, Rosmarin D

doi: 10.1111/jdv.16728.

AcneAtopic DermatitisPsoriasis

Mapping risk factors for Cumulative Life Course Impairment (CLCI) in patients with chronic skin diseases - a systematic review

J Eur Acad Dermatol Venereol

von Stülpnagel CC, Augustin M, Düpmann L, da Silva N, Sommer R

doi: 10.1111/jdv.17348

COMMENTED

Acne

Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa

JAMA Dermatol.

Reddy S, Strunk A, Garg A

doi: 10.1001/jamadermatol.

AcnePsoriasis

Hidradenitis Suppurativa Among Patients with Human Immunodeficiency Virus: Investigating Patient and Disease Characteristics, and Misdiagnosis

Br J Dermatol

Bui H, Skiba PN, Breskin A, Sayed C

doi: 10.1111/bjd.20591

Further Publications Immunology

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

JAMA.

Lemaitre M, Kirchgesner J, Rudnichi A, Carrat F, Zureik M, Carbonnel F, Dray-Spira R

doi: 10.1001/jama.2017.16071.

Gout

Prevalence, incidence and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017

Arthritis Rheumatol.

Safiri S, Kolahi AA, Cross M, Carson-Chahhoud K, Hoy D, Almasi-Hashiani A, Sepidarkish M, Ashrafi-Asgarabad A, Moradi-Lakeh M, Mansournia MA, Kaufman JS, Collins G, Woolf AD, March L, Smith E

doi: 10.1002/art.41404.

Acne

Incidence of Long-term Opioid Use Among Opioid-Naive Patients With Hidradenitis Suppurativa in the United States

JAMA Dermatol.

Reddy S, Orenstein LAV, Strunk A, Garg A

doi: 10.1001/jamadermatol.2019.2610.

Related content

Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease

High prevalence of alcohol use disorders in patients with inflammatory skin diseases

Risk of connective tissue disease, morphea and systemic vasculitis in patients with hidradenitis suppurativa

Mapping risk factors for Cumulative Life Course Impairment (CLCI) in patients with chronic skin diseases - a systematic review

Comparative Overall Comorbidity Burden Among Patients With Hidradenitis Suppurativa

Hidradenitis Suppurativa Among Patients with Human Immunodeficiency Virus: Investigating Patient and Disease Characteristics, and Misdiagnosis

Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease

Prevalence, incidence and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017

Incidence of Long-term Opioid Use Among Opioid-Naive Patients With Hidradenitis Suppurativa in the United States